IP Library Assignment 016022/0351
Patent Assignment
Reel/Frame 016022/0351

Assignment of Assignor's Interest

Recorded: 2005-05-17 Pages: 2
Assignor
HAR-NOY, MICHAEL
Executed: 2005-02-28
Assignee
IMMUNOVATIVE THERAPIES, LTD.
MISGAV TECHNOLOGY CENTER M.P., MISGAV, JERUSALEM, 20179, ISRAEL
Covered Property (1)
T-Cell Therapy Formulation
Patent: 7,402,431 →
Application: 11/069,010 →
Publication: US 2005/0214274
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Rescission Sep 12, 2019
From: HAR-NOY, MICHAEL
To: HAR-NOY, MICHAEL
Reel/Frame 050467/0081 →
Assignment of Assignor's Interest Sep 25, 2019
From: IMMUNOVATIVE THERAPIES, LTD.
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050489/0245 →
Corrective Assignment to Correct the Assignor's Name from Immunovative Therapies, Ltd. to Michael Har-Noy on the Original Cover Sheet Previously Recorded on Reel 050489 Frame 0245. Assignor(S) Hereby Confirms the Assignment. Oct 2, 2019
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 050610/0633 →
Corrective Assignment to Correct the Correct the Address Os the Assignee Previously Recorded at Reel: 050489 Frame: 0245. Assignor(S) Hereby Confirms the Assignment. Jan 28, 2020
From: HAR-NOY, MICHAEL
To: MIRROR BIOLOGICS, INC.
Reel/Frame 052915/0513 →